Apr 1, 2014) - (PIHN) is pleased to announce the Company has added Dr. Vasthi Alvarez Avila as Medical Director and to the Corporate Board of Directors. Dr. Alvarez Avila graduated from Universidad De Montemorelos in Mexico. She has 8 years of medical service in Family Practice and General Surgery throughout Mexico.
Dr. Alvarez Avila will be overseeing product trials preformed by the Company in the United States and as it makes further progress toward initiating trials in Mexico and India. Dr. Alverez said, "We want to establish our international brand and reputation for excellence, demonstrating through our professionally managed trials that our products represent the highest quality, most consistent dosage delivery results and prove to our participating physician base that we have a pharmaceutical grade solution that they can rely on." Polaris International Holdings is also currently in the process of procuring additional specialized Doctors internationally to conduct the trials.
Previous reports from The National Cancer Institute showing that the programmed death of breast cancer cell in presence of CBD and the possibility that CBD may also enhance uptake of cytotoxic drugs into certain malignant cells is very promising. A refined CBD completely void of THC a myriad of uses in a number of specialties including pain management, sports medicine, preventative medicine and oncology, possibly increasing the effectiveness of some chemotherapy.
"The healing powers of cannabinoids have only been touched upon in research. Without the THC psychotropic effects of medical marijuana, the general acceptance of the therapeutic qualities of marijuana will be more highly embraced by the general population and the risks of administering the CBD without THC to the elderly, and those with compromised health may be greatly decreased," states Dr. Alvarez Avila.
News 
Market Data 
Discover 
